Zimmer's shoulder replacement system Identity gets FDA clearance

Sep. 20, 2022 8:13 AM ETZimmer Biomet Holdings, Inc. (ZBH)By: Ravikash, SA News Editor

Headquarters of US Food and Drug Administration (FDA)


  • The U.S. Food and Drug Administration (FDA) granted 510(k) clearance to Zimmer Biomet's (NYSE:ZBH) Identity Shoulder System for anatomic, reverse and revision shoulder replacement.
  • The device is designed to allow surgeons to devise and execute a patient-specific surgical plan with precision, the company said in a Sept. 20 press release.
  • Zimmer noted that the new system expands its upper extremities portfolio, which includes the Comprehensive Nano Stemless Shoulder and the Signature ONE Surgical Planning System.

Recommended For You


To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.